Novartis And Fudan University To Set Up Cancer Research Lab

Novartis and Fudan University will jointly conduct research focusing on developing new approaches to understand the causes of cancer. The announcement was made at the groundbreaking ceremony of China Novartis Institutes For Biomedical Research in Shanghai that will accommodate more than 400 researchers in its phase I construction. Researchers from both Novartis Shanghai R&D Center and Fudan will work at a joint lab in the university campus, adopting innovative molecular genetics techniques to develop disease models for new target discovery for cancer therapy. The initial efforts will concentrate on research on liver cancer. (Click here for more - Chinese Language)